Multiple Sclerosis Clinical Trial

Quantitative Magnetic Resonance Imaging (MRI) Sub-Study of MS PATHS

Summary

The primary objective is to assess the performance of a new magnetic resonance imaging (MRI) metrics software prototype when used in radiological practice in multiple sclerosis (MS).

View Eligibility Criteria

Eligibility Criteria

Key Inclusion Criteria:

Board-certified neuroradiologists or experienced neuroradiology fellows.
Employed at a participating MS PATHS institution.
At least 3 years of experience in interpreting brain MRI scans of MS participants.

Key Exclusion Criteria:

Inability to comply with sub-study procedures.
Other unspecified reasons that, in the opinion of Biogen or the MS PATHS Radiology Lead at the institution, make the radiologist unsuitable for participation.

Study is for people with:

Multiple Sclerosis

Estimated Enrollment:

6

Study ID:

NCT04145284

Recruitment Status:

Completed

Sponsor:

Biogen

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 2 Locations for this study

See Locations Near You

Research Site
Cleveland Ohio, 44195, United States
Research Site
Dresden Saxony, 01307, Germany

How clear is this clinincal trial information?

Study is for people with:

Multiple Sclerosis

Estimated Enrollment:

6

Study ID:

NCT04145284

Recruitment Status:

Completed

Sponsor:


Biogen

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider